Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
7 drugs in development
By Therapeutic Area
top 6
R&D Momentum
80/100
Pipeline Velocity
54/100
Trial Completion Rate
70/100
Pipeline Concentration
23/100
Pipeline Freshness
70/100
Strategic Signals
Activity
Last 14 days
Feasibility Pilot Study of OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population Treated With Immune Checkpoint Inhibitors for Various Cancers
Self-Acceptance and Supportive Accountability for Active Living Among Adults Receiving Chemotherapy
Testing the Feasibility and Acceptability of a Remotely Delivered Program to Promote Active Living Among People With Advanced Cancer
Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)